Skip to Main Content

Paper Details

Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer.
Lab Invest
19
2021
AKT, CAG, CAG driven LGSL-KrasG12V allele, CreERT2, Hnf1b, K-Ras, Kras, Kras mutations, KrasG12V, Krasmut, LGSL-KrasG12V, MAPK, PDAC, PTEN, PanIN, Pancreatic Intraepithelial Neoplasia, Pancreatic ductal adenocarcinoma, Ras, TP53, cKras, cKrasHigh, cKrasHnf1b/+, cKrasLow, cKrasMod, cancer, ductal derived pancreatic intraepithelial neoplasia, human, mature pancreatic cells, mice, neoplasia, oncogenic mutant K-Ras, oncogenic mutant Kras, pancreatic, pancreatic cancer, patients, tamoxifen, tumor, tumor suppressor, tumors
Author NameAffiliation
Nirav ThosaniMcGovern Medical School, The University of Texas Health Science Center
Anirban MaitraThe University of Texas MD Anderson Cancer Center
Florencia McAllisterThe University of Texas MD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2